Company: MVIS
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021931
Chunk: 38

Company: MICROVISION, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 3
Chunk 38
---
the second quarter of 2021, we identified a material weakness in the controls that support our determination of the grant date of equity
awards. If we identify further material weaknesses in our internal controls, our failure to establish and maintain effective disclosure
controls and procedures and internal control over financial reporting could result in material misstatements in our financial statements
and a failure to meet our reporting obligations. Any such failure could cause investors to lose confidence in the accuracy of our financial
reports, harm our reputation, and adversely affect the market price of our common stock.

Our
internal controls over financial reporting beginning for fiscal year 2024 include controls of our subsidiary, MicroVision GmbH, which
became a significant subsidiary upon the closing of our acquisition of assets from Ibeo in 2023. Given the added complexity stemming
from the inclusion of our German subsidiary within our control environment, the risk of a material weakness in internal controls will
be higher than it has been to date.

Our
stock price has fluctuated in the past, has recently been volatile and may be volatile in the future, and as a result, investors in our
common stock could incur substantial losses.

Our
stock price has fluctuated significantly in the past, has recently been volatile, and may be volatile in the future. Over the 52-week
period ending November 5, 2025, our common stock has traded at a low of $0.80 and a high of $1.95. We may continue to experience sustained
depression or substantial volatility in our stock price in the foreseeable future unrelated to our operating performance or prospects.
For the nine months ended September 30, 2025, we incurred a loss per share of $0.22.

As
a result of this volatility, investors may experience losses on their investment in our common stock. The market price for our common
stock may be influenced by many factors, including the following:

 ●investor
                                            reaction to our business strategy;

 ●the
                                            success of competitive products or technologies;
     
 ●strategic
                                            developments;
     
 ●the
                                            timing and results of our development and commercialization efforts with respect to our perception
                                            solutions and lidar sensors;
     
 ●changes
                                            in regulatory or industry standards applicable to our solutions or technologies;

 ●variations
                                            in our or our competitors’ financial and operating results;

 ●developments
                                            concerning our collaborations or partners;
     
 ●developments
                                            or disputes with any